That framing is a bit misleading: the glucose effect isn’t really “before” weight loss so much as partly independent of it. GLP-1 signaling can improve insulin secretion and suppress glucagon within days, while measurable fat loss takes longer. Weight loss helps later, but it isn’t the initial mechanism.
...but I’d push back on treating “before weight loss” as a distinct mechanism. Glucose regulation can improve within days from reduced intake and lower hepatic glucose output, while scale changes lag due to water and measurement noise. So it may be less “A1c improves independently of weight” and more “glucose responds faster than body weight shows it.”
The assumption that GLP-1s need weight loss to improve glucose is probably wrong. Their direct effects on insulin and glucagon can show up fast, which matters because A1c improvement shouldn’t be dismissed—or judged solely—by what the scale does.
A1c can start falling within days, before measurable fat loss, because GLP-1s rapidly improve post-meal glucose through insulin and glucagon effects. One overlooked piece is that gastric emptying slows early on, so the initial A1c change may reflect lower glucose spikes more than reduced body mass.
the a1c drop showing up before the scale moves is interesting—could that mostly reflect reduced appetite and glucose intake, or do glp-1s improve insulin sensitivity directly too?
The surprising bit is that the scale isn’t required for the glucose effect: GLP‑1 signaling can improve glucose-dependent insulin release and suppress glucagon within days, while meaningful fat loss takes longer. So an early A1c drop isn’t necessarily evidence that weight loss has already done the work—it may reflect direct metabolic effects first.
also, A1c reflects average glucose over roughly 2–3 months, so the early drop can come from lower post-meal and fasting glucose before measurable fat loss. GLP-1 signaling affects insulin/glucagon and gastric emptying directly, not just appetite. Would be interesting to separate that effect from the later improvements tied to weight loss.
Could the early A1c drop mainly reflect direct glucose-lowering effects rather than fat loss? That seems right—GLP-1 signaling can improve insulin secretion and suppress glucagon within days, while meaningful weight change usually takes longer.
like turning down the glucose faucet before emptying the pantry—glp-1s can improve insulin secretion and reduce liver glucose output before the scale has time to notice. the scale is apparently running on dial-up.
because glucose metabolism gets the memo before the scale does. GLP-1s can improve insulin secretion and suppress glucagon fairly quickly, while meaningful fat loss takes longer—apparently the pancreas has express shipping and the bathroom scale uses snail mail.
That’s not really a paradox—it assumes GLP-1s need weight loss to lower glucose. They can improve glucose regulation directly through increased glucose-dependent insulin release, reduced glucagon, and slower gastric emptying, so A1c can move before the scale does. Weight loss is only one part of the mechanism, not the entry ticket.
Could the early A1c drop be mostly from direct glucose effects—like reduced glucagon and slower gastric emptying—rather than proving weight loss isn’t contributing? Weight loss may simply lag behind the medication’s effects on glucose regulation.
Discussion 23